CTOs on the Move

May Institute

www.mayinstitute.org

 
May Institute is an award-winning nonprofit organization that provides educational, rehabilitative, and behavioral healthcare services to individuals with autism spectrum disorders and other developmental disabilities, brain injury, mental illness, and behavioral health needs. The Institute also provides training and consultation services to professionals, organizations, and public school systems. The organization is one of the largest and most well-respected providers of services and special education schools for children and adults with autism and other special needs in Massachusetts and in the U.S. Since its founding nearly 60 years ago, May Institute has evolved into a national network that serves thousands of individuals and ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

High Cotton Direct Marketing

High Cotton Direct Marketing is a Birmingham, AL-based company in the Business Services sector.

Ejento

Recruiting top technical and professional talent at the speed of startup. Were advancing companies (and careers) fast. Ejento is the culmination of four visionary firms: NeoHire South, RockIT Recruiting, TS2, and Hero.jobs.

Prism Network Solutions

Prism Network Solutions, Llc is a Fultondale, AL-based company in the Business Services sector.

Mobile Expressions Inc

Mobile Expressions Inc is a Decatur, GA-based company in the Business Services sector.

AmpliPhi Biosciences

AmpliPhi Biosciences Corporation (NYSEMKT: APHB) is a biotechnology company focused on the development and commercialization of novel bacteriophage-based antibacterial therapeutics. AmpliPhi`s product development programs target infections that are often resistant to existing antibiotic treatments. AmpliPhi is collaborating with a number of leading organizations, including Intrexon Corporation (NYSE: XON), the U.S. Army, The Royal Brompton Hospital in London, UK and UK-based University of Leicester, to rapidly advance bacteriophage-based therapies.